perindopril has been researched along with Insulin Resistance in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krysiak, R; Okopień, B | 2 |
| Fisun, NI; Nazarov, AG; Nechaeva, GI; Novikov, AI; Pritykina, TV; Semenkin, AA; Zhivilova, LA | 1 |
| An, C; Chen, A; Hu, Y; Jiang, Y; Li, Q; Lu, L; Niu, C; Shu, L; Yang, Z; Yu, X; Zhou, L | 1 |
| Głuszek, J; Jankowska, K | 1 |
| Chen, YH; Chen, YY; Qi, CJ; Yuan, L | 1 |
| Aihara, Y; Fujimoto, M; Fukui, H; Ikenaka, Y; Kaji, K; Mitoro, A; Morioka, C; Noguchi, R; Sawai, M; Toyohara, M; Uemura, M; Yamao, J; Yamazaki, M; Yoshida, M; Yoshiji, H | 1 |
| Aihara, Y; Douhara, A; Fujimoto, M; Fukui, H; Ikenaka, Y; Kaji, K; Mitoro, A; Morioka, C; Noguchi, R; Sawai, M; Toyohara, M; Uemura, M; Yamao, J; Yoshida, M; Yoshiji, H | 1 |
| Chumachok, EV; Lediaeva, AA; Mazina, GG; Nedogoda, SV; Salasiuk, AS; Tsoma, VV | 1 |
| Kinugawa, S | 1 |
| Leye, A; Marre, M | 1 |
| Bijlstra, PJ; Lutterman, JA; Smits, P; Thien, T | 1 |
| Corradi, L; Fogari, R; Lazzari, P; Lusardi, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Chen, D; Lin, J; Wu, K | 1 |
| Kuperstein, R; Sasson, Z | 1 |
2 review(s) available for perindopril and Insulin Resistance
| Article | Year |
|---|---|
[Diabetic heart disease].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Heart Failure; Humans; Insulin Resistance; Myocardial Contraction; Myocardial Infarction; Perindopril; Tetrazoles; Ventricular Remodeling | 2007 |
Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin Resistance; Models, Biological; Perindopril | 2007 |
7 trial(s) available for perindopril and Insulin Resistance
| Article | Year |
|---|---|
Different effects of perindopril and enalapril on monocyte cytokine release in coronary artery disease patients with normal blood pressure.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Blood Pressure; Cells, Cultured; Chi-Square Distribution; Coronary Artery Disease; Cytokines; Enalapril; Female; Humans; Inflammation Mediators; Insulin Resistance; Lipids; Male; Middle Aged; Monocytes; Perindopril; Poland; Time Factors; Treatment Outcome | 2012 |
Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trial.
Topics: Aged; Amino Acids, Branched-Chain; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Humans; Insulin Resistance; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Perindopril; Treatment Outcome | 2011 |
Combination of branched-chain amino acid and angiotensin-converting enzyme inhibitor improves liver fibrosis progression in patients with cirrhosis.
Topics: Amino Acids, Branched-Chain; Angiotensin-Converting Enzyme Inhibitors; Collagen Type IV; Drug Therapy, Combination; Female; Humans; Hyaluronic Acid; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged; Perindopril; Transforming Growth Factor beta; Treatment Outcome | 2012 |
Lymphocyte-suppressing action of angiotensin-converting enzyme inhibitors in coronary artery disease patients with normal blood pressure.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Case-Control Studies; Coronary Artery Disease; Cytokines; Double-Blind Method; Enalapril; Female; Humans; Insulin Resistance; Lipids; Lymphocytes; Male; Middle Aged; Perindopril; Phytohemagglutinins; Prospective Studies; Time Factors | 2011 |
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Hemodynamics; Humans; Hypertension; Indoles; Insulin Resistance; Losartan; Male; Middle Aged; Obesity; Perindopril | 1998 |
[The effect of amlodipine, nifedipine and perindopril on insulin sensitivity and blood lipid of patients with essential hypertension].
Topics: Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Female; Humans; Hypertension; Insulin Resistance; Lipids; Male; Middle Aged; Nifedipine; Perindopril | 1998 |
Effects of antihypertensive therapy on glucose and insulin metabolism and on left ventricular mass: A randomized, double-blind, controlled study of 21 obese hypertensives.
Topics: Antihypertensive Agents; Atenolol; Double-Blind Method; Female; Glucose; Heart Ventricles; Humans; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Myocardium; Obesity; Perindopril; Ventricular Function, Left | 2000 |
6 other study(ies) available for perindopril and Insulin Resistance
| Article | Year |
|---|---|
[Endothelial and metabolic effects of perindopril in patients with essential hypertension].
Topics: Antihypertensive Agents; Blood Pressure; Body Mass Index; Brachial Artery; Endothelium, Vascular; Essential Hypertension; Female; Glucose; Humans; Hypertension; Insulin Resistance; Lipids; Male; Middle Aged; Perindopril; Treatment Outcome; Ultrasonography; Vasodilation; Waist Circumference | 2014 |
Resistin Induces Hypertension and Insulin Resistance in Mice via a TLR4-Dependent Pathway.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Cell Line, Tumor; Hep G2 Cells; Humans; Hypertension; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Perindopril; Renin-Angiotensin System; Resistin; Toll-Like Receptor 4; Transcription Factor RelA | 2016 |
Is there relationship between the A1166C polymorphism of the angiotensin II receptor AT1 and plasma renin activity, insulin resistance and reduction of blood pressure after angiotensin-converting enzyme inhibitor therapy?
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Female; Genotype; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Perindopril; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Renin | 2008 |
[The effects of renin-angiotensin system blockade on the liver steatosis in rats on long-term high-fat diet].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Dietary Fats; Fatty Liver; Immunohistochemistry; Insulin Resistance; Ion Channels; Liver; Male; Mitochondrial Proteins; Perindopril; Rats; Rats, Wistar; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Time Factors; Transforming Growth Factor beta1; Uncoupling Protein 2; Valine; Valsartan | 2008 |
[Efficiency perindopril at patients with arterial hypertension and obesity].
Topics: Adipose Tissue; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Mass Index; Drug Monitoring; Enalapril; Female; Heart Function Tests; Humans; Hypertension; Insulin Resistance; Kidney Function Tests; Male; Metabolism; Middle Aged; Obesity; Perindopril; Protective Agents; Therapeutic Equivalency; Treatment Outcome | 2011 |
Effect of long-term angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Forearm; Humans; Indoles; Injections, Intra-Arterial; Insulin Resistance; Male; Methacholine Chloride; Middle Aged; Nitroprusside; Perindopril; Regional Blood Flow; Vasodilation | 1995 |